A Nevada judge has barred prediction market platform Polymarket from operating in the state, leaning on recent federal rulings against similar platforms. The decision marks a significant setback for the company's regulated U.S. relaunch and underscores the ongoing legal tension between state gambling laws and federal commodities regulations.
A new report from crypto market maker Wintermute Ventures forecasts a seismic shift, arguing that blockchain-based prediction markets will begin displacing traditional insurance by making hyper-specific risks tradable. The firm outlines a future where decentralized infrastructure becomes the new clearing layer for a programmable global economy.
As economic pressures mount, flexible remote work opportunities are evolving. We examine four proven side gigs that experts project can still generate significant weekly earnings from home in the coming years.
Goldman Sachs Group (GS) has approved a significant dividend increase and projects a robust earnings outlook for Corporate America, fueling debate over whether its strong share price momentum has outpaced its fundamental valuation.
A revised analyst price target for Grupo Financiero Banorte (BMV:GFNORTE O) is refocusing investor attention on the Mexican banking giant, highlighting how evolving assessments of risk and growth potential can rapidly reshape a stock's narrative.
While analyst price targets often paint a rosy picture, a deeper look reveals which recommendations are backed by solid business trends and which may be overly optimistic. We examine one fintech disruptor and one industrial stalwart favored by the Street, alongside a retailer facing significant headwinds.
Following a staggering 92.9% one-year surge, Commerzbank shares have cooled slightly. With the stock now trading around €34.69, analysts are divided: deep-value models signal significant upside, while traditional metrics suggest a fair price. We examine the data and the debate shaping one of Germany's banking turnaround stories.
JPMorgan Chase confronts heightened regulatory and political pressure as a lawsuit from former President Donald Trump alleges biased account closures, while CEO Jamie Dimon's public spat with Coinbase underscores the intensifying battle between traditional banks and crypto platforms for customer funds.
Former Federal Reserve Governor Kevin Warsh has been nominated by former President Donald Trump to chair the central bank, a move lauded by business leaders who cite his crisis-era experience and market savvy.
Facing its weakest annual profit in years, Eastman Chemical is doubling down on cost reductions while banking on its molecular recycling technology to fuel a turnaround by 2026, despite a challenging global economic climate.
As the Bank of England prepares for a leadership transition in 2028, a debate ignited by former Fed governor Kevin Warsh gains traction: should central banks shed ancillary roles and return to their core mission of price stability?
President Trump's nomination of Kevin Warsh to lead the Federal Reserve has sent ripples through cryptocurrency markets, as traders assess the implications of a governor with direct crypto investment experience and a hawkish monetary policy reputation.
A bold congressional proposal to cap credit card interest rates at 10% is drawing sharp criticism from Wall Street and raising fundamental questions about the future profitability of card issuers like American Express.
The Centers for Medicare & Medicaid Services (CMS) has unveiled a proposed payment update for Medicare Advantage plans that falls below industry expectations, coupled with stricter risk-adjustment regulations. This dual challenge pressures insurers like Oscar Health (NYSE: OSCR), whose tech-driven model is now under the microscope as profitability margins face a squeeze.
Facing headwinds from tariffs, a soft housing market, and intense promotions, Whirlpool reported flat organic revenue for 2025. Executives outlined a plan to improve margins and cash flow in the coming year, banking on pricing normalization and new product launches.
Swiss banking giant UBS has initiated coverage on Zai Lab Limited (NASDAQ: ZLAB) with a bullish 'Buy' rating and a $35 price target, highlighting the biopharma firm's strategic pivot from a China-focused player to a burgeoning global innovation platform with a promising proprietary pipeline.
Shares of Huntington Bancshares (HBAN) have climbed over 17% in the past 90 days, closing recently at $17.88. This rally has investors scrutinizing whether the regional bank's stock still holds value after its strong run, with some models suggesting a significant upside to fair value.
Despite strong performance from the Latin American e-commerce and fintech leader, investment manager Triasima reduced its position, highlighting portfolio discipline over bearish sentiment.
Newly unsealed documents from the Jeffrey Epstein case include a forwarded email detailing the 2019 uproar over Coinbase's acquisition of Neutrino, underscoring the late financier's apparent interest in crypto industry crises and their intersection with power.
Precious metals markets are reeling after their sharpest single-day decline since 1980, yet major Wall Street institutions reaffirm ambitious year-end price targets, citing enduring structural drivers.
